Application Note: Preclinical Cardiac Safety Assessment using Human iPSC-Derived iCell™ Cardiomyocytes
9 July 2015

In this application note, human induced pluripotent stem (iPS) cell-derived cardiomyocytes together with the new xCELLigence System RTCA Cardio Instrument were demonstrated as an assay system for preclinical in vitro cardiac safety assessment.